GO2 for Lung Cancer serves and listens to those living with and at risk for lung cancer to reduce stigma, improve quality of life and increase survival.
We empower our community by helping people navigate the paths of early detection, diagnosis and treatment. Insights allow us to improve care, amplify awareness, drive advocacy and lead research. GO2 for Lung Cancer is uniquely poised to take doubling the five-year lung cancer survival rate to 40% over the next four years.
For media inquiries, please contact: Julia Spiess, senior director, communications, at jspiess@go2.org or 916-601-8282.
Connect with GO2 for Lung Cancer:
.
Snapshot – Lung Cancer Facts1
It is estimated that nearly 237,000 Americans will be diagnosed with lung cancer this year.
Lung cancer is the leading cause of cancer death in the United States, but receives the least amount of federal research funding.2
Lung cancer claims more lives annually than either colorectal, pancreatic, breast, or prostate.
1Siegel, RL, Miller, KD, Fuchs, H, Jemal, A. Cancer Statistics, 2022. CA Cancer J Clin. 2022: 72(1):7-33
2“Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC).” NIH Research Portfolio Online Reporting Tools, U.S. Department of Health and Human Services, https://report.nih.gov/categorical_spending.aspx
Press Releases
GO2 for Lung Cancer Honors and Celebrates Its Community at 19th Annual Simply the Best Gala
GO2 for Lung Cancer (GO2) recognized lung cancer champions at its 19th Annual Simply the [...]
GO2 for Lung Cancer to Present Awards to Partners Who Have Gone Above and Beyond to Confront Lung Cancer
WASHINGTON, Oct. 23, 2024—GO2 for Lung Cancer (GO2) will honor Novocure at its 19th annual [...]
Physician and Patient Groups Urge USPSTF and CMS to Update and Expand Lung Cancer Screening Eligibility and Criteria
Changes could impact an additional 5 million people at higher risk for lung cancer WASHINGTON, July [...]
GO2 for Lung Cancer, Dana-Farber Cancer Institute, and Addario Lung Cancer Medical Institute Announce Expansion of Landmark Patient Research on Underlying Causes of Inherited Risk of Lung Cancer
Clinical Trial Aims to Unlock the Origins of Lung Cancer WASHINGTON and BOSTON, April 17, [...]